These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1834644)

  • 21. A soluble form of the interleukin-1 receptor produced by a human B cell line.
    Symons JA; Duff GW
    FEBS Lett; 1990 Oct; 272(1-2):133-6. PubMed ID: 1699802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
    McMahan CJ; Slack JL; Mosley B; Cosman D; Lupton SD; Brunton LL; Grubin CE; Wignall JM; Jenkins NA; Brannan CI
    EMBO J; 1991 Oct; 10(10):2821-32. PubMed ID: 1833184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of IL-1 alpha effectiveness in activating murine pre-B and T cell lines.
    Iwasaki T; Sims JE; Grabstein K; Dower SK; Rachie N; Bomsztyk K
    Cytokine; 1993 Sep; 5(5):416-26. PubMed ID: 8142596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.
    Malyak M; Smith MF; Abel AA; Arend WP
    J Clin Immunol; 1994 Jan; 14(1):20-30. PubMed ID: 8132734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor.
    Juric DM; Carman-Krzan M
    Int J Dev Neurosci; 2001 Nov; 19(7):675-83. PubMed ID: 11705672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model.
    Thomas TK; Will PC; Srivastava A; Wilson CL; Harbison M; Little J; Chesonis RS; Pignatello M; Schmolze D; Symington J
    Agents Actions; 1991 Sep; 34(1-2):187-90. PubMed ID: 1838896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus induces GM-CSF synthesis by monocytes: effect on EBV-induced IL-1 and IL-1 receptor antagonist production in neutrophils.
    Roberge CJ; Larochelle B; Rola-Pleszczynski M; Gosselin J
    Virology; 1997 Nov; 238(2):344-52. PubMed ID: 9400607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants.
    Nicod LP; el Habre F; Dayer JM
    Cytokine; 1992 Jan; 4(1):29-35. PubMed ID: 1535518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
    Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
    Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.
    Dower SK; Call SM; Gillis S; Urdal DL
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1060-4. PubMed ID: 2937055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
    Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
    J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1 alpha and IL-1 beta binding sites.
    Benjamin D; Wormsley S; Dower SK
    J Biol Chem; 1990 Jun; 265(17):9943-51. PubMed ID: 2141025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor.
    Loscher CE; Mills KH; Lynch MA
    J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues.
    Steinkasserer A; Solari R; Mott HR; Aplin RT; Robinson CC; Willis AC; Sim RB
    FEBS Lett; 1992 Sep; 310(1):63-5. PubMed ID: 1388125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
    Ulich TR; Guo K; Yin S; del Castillo J; Yi ES; Thompson RC; Eisenberg SP
    Am J Pathol; 1992 Jul; 141(1):61-8. PubMed ID: 1385928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.